Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Developments in Genetics – a Better Management of Ovarian Cancer Patients

Version 1 : Received: 27 September 2023 / Approved: 29 September 2023 / Online: 29 September 2023 (12:00:47 CEST)

A peer-reviewed article of this Preprint also exists.

Maioru, O.-V.; Radoi, V.-E.; Coman, M.-C.; Hotinceanu, I.-A.; Dan, A.; Eftenoiu, A.-E.; Burtavel, L.-M.; Bohiltea, L.-C.; Severin, E.-M. Developments in Genetics: Better Management of Ovarian Cancer Patients. Int. J. Mol. Sci. 2023, 24, 15987. Maioru, O.-V.; Radoi, V.-E.; Coman, M.-C.; Hotinceanu, I.-A.; Dan, A.; Eftenoiu, A.-E.; Burtavel, L.-M.; Bohiltea, L.-C.; Severin, E.-M. Developments in Genetics: Better Management of Ovarian Cancer Patients. Int. J. Mol. Sci. 2023, 24, 15987.

Abstract

The purpose of this article is to highlight the new advancements in molecular and diagnostic genetic testing as well as properly classify all ovarian cancers. In this article we address statistics, histopathological classification, molecular pathways implicated in ovarian cancer, genetic screening panels and details about the genes, and also candidate genes. We hope to bring new information in the medical field as to better prevent and diagnose ovarian cancer.

Keywords

Ovarian; Molecular; Genetics; Pathways; Diagnosis; Screening; Panel

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.